Skip Navigation


European Heart Journal Advance Access originally published online on November 10, 2006
European Heart Journal 2007 28(1):3-4; doi:10.1093/eurheartj/ehl377
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/1/3    most recent
ehl377v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wang, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Diabetes mellitus and insulin therapy in infective endocarditis

Andrew Wang

Division of Cardiovascular Medicine, Duke University Medical Center, DUMC 3428, Durham, NC 27710, USA

Corresponding author. Tel: +1 919 643 1674; fax: +1 919 681 7917. E-mail address: a.wang@duke.edu

This editorial refers to ‘Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality’{dagger} by X. Duval et al., on page 59

The first 10% of the full text of this article appears below.

Infective endocarditis (IE) is an uncommon disease but is associated with substantial morbidity and mortality. In the contemporary era, despite advancements in diagnosis and both antimicrobial and surgical therapies, IE is associated with an in-hospital mortality rate of nearly 20%.1,2 Given this high mortality, numerous studies have investigated clinical characteristics of IE that are associated with poor outcome. On the basis of such observational studies, current consensus guidelines for the evaluation and treatment of IE3,4 outline complications of IE that are indications for cardiac surgery in active IE.

In addition to describing prognostic complications of IE, observational studies have identified demographic, echocardiographic, and microbiologic characteristics associated . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality
Xavier Duval, François Alla, Thanh Doco-Lecompte, Vincent Le Moing, François Delahaye, Jean-Luc Mainardi, Patrick Plesiat, Marie Célard, Bruno Hoen, Catherine Leport, and for the Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI)
EHJ 2007 28: 59-64. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
S. D. Kristensen, H. Baumgartner, H. Drexler, E. Eeckhout, G. Filippatos, A. K. Gitt, C. Linde, L. A. Pierard, D. Poldermans, H. Schunkert, et al.
Highlights of the 2007 Scientific Sessions of the European Society of Cardiology: Vienna, Austria, September 1 5, 2007
J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2421 - 2430.
[Full Text] [PDF]